PlexusDx serves all 50 states and accepts HSA and FSA funds, making treatment accessible to employed and self-employed patients alike
[14] Patients who encounter websites or clinics offering retatrutide for purchase or prescription in the UK at this time should be aware that: No licensed supply chain exists for this medicine in the UK Unlicensed medicines carry significant safety risks , including unknown purity, dosing inaccuracies, and absence of pharmacovigilance oversight Products marketed as 'research peptides' or compounded retatrutide are not subject to MHRA quality controls and should not be used outside of authorised trials The MHRA advises consumers to obtain medicines only from General Pharmaceutical Council (GPhC)-registered pharmacies and with a valid prescription from a regulated prescriber
According to researchers from Johns Hopkins, women who take GLP-1 RAs lose an average of 11% of their starting weight after 43 weeks of treatment
Originally developed as a therapeutic agent for metabolic conditions, semaglutide has become one of the most actively researched peptides in clinical and preclinical settings
The timeline for the availability of Retarutide is uncertain, but it might become available by 2026-2027
Polley pointed out that even patients with similar clinical profiles might prioritize different aspects of their health or quality of life